Diagnosis and prevention of thalassemia

References

• Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86:480–7
   PubMed Web of Science ®Google Scholar
• Lau YL, Chan LC, Chan YY, et al. Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong – implications for population screening. N Engl J Med 1997;336:1298–301
   PubMed Web of Science ®Google Scholar
• Fucharoen S, Winichagoon P. Haemoglobinopathies in southeast Asia. Indian J Med Res 2011;134:498–506
   PubMedGoogle Scholar
• Chan LC, Ma SK, Chan AY, et al. Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia? J Clin Pathol 2001;54:317–20
   PubMed Web of Science ®Google Scholar
• Ma ES, Chan AY, Ha SY, et al. Thalassemia screening based on red cell indices in the Chinese. Haematologica 2001;86:1310–1
   PubMed Web of Science ®Google Scholar
• Ryan K, Bain BJ, Worthington D, et al. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol 2010;149:35–49
   PubMed Web of Science ®Google Scholar
• Tang W, Luo HY, Albitar M, et al. Human embryonic zeta-globin chain expression in deletional alpha-thalassemias. Blood 1992;80:517–22
   PubMedGoogle Scholar
• Lafferty JD, Crowther MA, Waye JS, Chui DH. A reliable screening test to identify adult carriers of the (–SEA) alpha zero-thalassemia deletion. Detection of embryonic zeta-globin chains by enzyme-linked immunosorbent assay. Am J Clin Pathol 2000;114:927–31
   PubMedGoogle Scholar
• Lafferty JD, Barth DS, Sheridan BL, et al. A multicenter trial of the effectiveness of zeta-globin enzyme-linked immunosorbent assay and hemoglobin H inclusion body screening for the detection of alpha0-thalassemia trait. Am J Clin Pathol 2008;129:309–15
   PubMed Web of Science ®Google Scholar
• Tayapiwatana C, Kuntaruk S, Tatu T, et al. Simple method for screening of alpha-thalassaemia 1 carriers. Int J Hematol 2009;89:559–67
   PubMed Web of Science ®Google Scholar
• Srivorakun H, Fucharoen G, Changtrakul Y, et al. Thalassemia and hemoglobinopathies in Southeast Asian newborns: diagnostic assessment using capillary electrophoresis system. Clin Biochem 2011;44:406–11
   PubMed Web of Science ®Google Scholar
• Wild BJ, Stephens AD. The use of automated HPLC to detect and quantitate haemoglobins. Clin Lab Haematol 1997;19:171–6
   PubMedGoogle Scholar
• Winichagoon P, Svasti S, Munkongdee T, et al. Rapid diagnosis of thalassemias and other hemoglobinopathies by capillary electrophoresis system. Transl Res 2008;152:178–84
   PubMed Web of Science ®Google Scholar
• Trent RJ, Webster B, Bowden DK, et al. Complex phenotypes in the haemoglobinopathies: recommendations on screening and DNA testing. Pathology 2006;38:507–19
   Web of Science ®Google Scholar
• Clark BE, Thein SL. Molecular diagnosis of haemoglobin disorders. Clin Lab Haematol 2004;26:159–76
   PubMedGoogle Scholar
• Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies [Internet]. 2004. Available from: http://globin.cse.psu.edu/hbvar/menu.html [last accessed 1 May 2013]
   Google Scholar
• Chan AY, So CC, Ma ES, Chan LC. A laboratory strategy for genotyping haemoglobin H disease in the Chinese. J Clin Pathol 2007;60:931–4
   PubMed Web of Science ®Google Scholar
• Wang W, Kham SK, Yeo GH, et al. Multiplex minisequencing screen for common Southeast Asian and Indian beta-thalassemia mutations. Clin Chem 2003;49:209–18
   PubMed Web of Science ®Google Scholar
• Yip SP, Pun SF, Leung KH, Lee SY. Rapid, simultaneous genotyping of five common Southeast Asian beta-thalassemia mutations by multiplex minisequencing and denaturing HPLC. Clin Chem 2003;49:1656–9
   PubMed Web of Science ®Google Scholar
• Liao HK, Su YN, Kao HY, et al. Parallel minisequencing followed by multiplex matrix-assisted laser desorption/ionization mass spectrometry assay for beta-thalassemia mutations. J Hum Genet 2005;50:139–50
   PubMed Web of Science ®Google Scholar
• So CC, So AC, Chan AY, et al. Detection and characterisation of beta-globin gene cluster deletions in Chinese using multiplex ligation-dependent probe amplification. J Clin Pathol 2009;62:1107–11
   PubMed Web of Science ®Google Scholar
• Liew M, Pryor R, Palais R, et al. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin Chem 2004;50:1156–64
   PubMed Web of Science ®Google Scholar
• Liu YN, Li R, Zhou JY, et al. Screening for mutations in the alpha-globin genes leading to abnormal hemoglobin variants with high resolution melting analysis. Clin Chem Lab Med 2012;50:273–7
   Google Scholar
• Shih HC, Er TK, Chang TJ, et al. Rapid identification of HBB gene mutations by high-resolution melting analysis. Clin Biochem 2009;42:1667–76
   PubMed Web of Science ®Google Scholar
• Montgomery JL, Sanford LN, Wittwer CT. High-resolution DNA melting analysis in clinical research and diagnostics. Expert Rev Mol Diagn 2010;10:219–40
   PubMed Web of Science ®Google Scholar
• Cremonesi L, Ferrari M, Giordano PC, et al. An overview of current microarray-based human globin gene mutation detection methods. Hemoglobin 2007;31:289–311
   PubMed Web of Science ®Google Scholar
• Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002;30:e57
   PubMed Web of Science ®Google Scholar
• Viprakasit V, Kidd AM, Ayyub H, et al. De novo deletion within the telomeric region flanking the human alpha globin locus as a cause of alpha thalassaemia. Br J Haematol 2003;120:867–75
   PubMed Web of Science ®Google Scholar
• Koenig SC, Becirevic E, Hellberg MS, et al. Sickle cell disease caused by heterozygosity for Hb S and novel LCR deletion: Report of two patients. Am J Hematol 2009;84:603–6
   PubMedGoogle Scholar
• Joly P, Lacan P, Garcia C, et al. A novel deletion/insertion caused by a replication error in the beta-globin gene locus control region. Hemoglobin 2011;35:316–22
   PubMed Web of Science ®Google Scholar
• Coelho A, Picanco I, Seuanes F, et al. Novel large deletions in the human alpha-globin gene cluster: Clarifying the HS-40 long-range regulatory role in the native chromosome environment. Blood Cells Mol Dis 2010;45:147–53
   PubMed Web of Science ®Google Scholar
• Nezhat N, Akbari MT. Detection of deletions/duplications in alpha-globin gene cluster by multiplex ligation-dependent probe amplification. Genet Test Mol Biomarkers 2012;16:684–8
   Google Scholar
• Gibbons RJ, Wada T. ATRX mutations and X-linked alpha thalassaemia mental retardation syndrome. In: Epstein CJ, Erickson RP, Wynshaw-Boris A, editors. Inborn errors of development. Oxford: Oxford University Press, 2004:747--57
   Google Scholar
• Gibbons RJ, Pellagatti A, Garrick D, et al. Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS). Nat Genet 2003;34:446–9
   PubMed Web of Science ®Google Scholar
• Yu C, Niakan KK, Matsushita M, et al. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood 2002;100:2040–5
   PubMed Web of Science ®Google Scholar
• Viprakasit V, Gibbons RJ, Broughton BC, et al. Mutations in the general transcription factor TFIIH result in beta-thalassaemia in individuals with trichothiodystrophy. Hum Mol Genet 2001;10:2797–802
   PubMed Web of Science ®Google Scholar
• Lorey F, Cunningham G, Vichinsky EP, et al. Universal newborn screening for Hb H disease in California. Genet Test 2001;5:93–100
   PubMedGoogle Scholar
• Kemper AR, Knapp AA, Metterville DR, et al. Weighing the evidence for newborn screening for Hemoglobin H disease. J Pediatr 2011;158:780–3
   PubMed Web of Science ®Google Scholar
• Bouva MJ, Sollaino C, Perseu L, et al. Relationship between neonatal screening results by HPLC and the number of alpha-thalassaemia gene mutations; consequences for the cut-off value. J Med Screen 2011;18:182–6
   PubMed Web of Science ®Google Scholar
• Mitchell JJ, Capua A, Clow C, Scriver CR. Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools. Am J Hum Genet 1996;59:793–8
   PubMed Web of Science ®Google Scholar
• Lena-Russo D, Badens C, Aubinaud M, et al. Outcome of a school screening programme for carriers of haemoglobin disease. J Med Screen 2002;9:67–9
   PubMed Web of Science ®Google Scholar
• Zeinalian M, Nobari RF, Moafi A, et al. Two decades of pre-marital screening for beta-thalassemia in central Iran. J Community Genet 2013;4:517--22
   Google Scholar
• Samavat A, Modell B. Iranian national thalassaemia screening programme. Br Med J 2004;329:1134–7
   PubMed Web of Science ®Google Scholar
• Karimi M, Rasekhi AR. Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran. Haematologia (Budap) 2002;32:129–33
   PubMedGoogle Scholar
• Kwan WY, So CH, Chan WP, et al. Re-emergence of late presentations of fetal haemoglobin Bart's disease in Hong Kong. Hong Kong Med J 2011;17:434–40
   PubMedGoogle Scholar
• Wiwanitkit V, Suwansaksri J, Paritpokee N. Combined one-tube osmotic fragility (OF) test and dichlorophenol-indolphenol (DCIP) test screening for hemoglobin disorders, an experience in 213 Thai pregnant women. Clin Lab 2002;48:525–8
   PubMedGoogle Scholar
• Rogers M, Phelan L, Bain B. Screening criteria for beta thalassaemia trait in pregnant women. J Clin Pathol 1995;48:1054–6
   PubMedGoogle Scholar
• Wattanasirichaigoon D, Promsonthi P, Chuansumrit A, et al. Maternal uniparental disomy of chromosome 16 resulting in hemoglobin Bart's hydrops fetalis. Clin Genet 2008;74:284–7
   PubMed Web of Science ®Google Scholar
• Kwan Ma ES, Yin Chan AY, et al. Screening for (–SEA) alpha-globin gene deletion in beta-thalassemia carriers and prevention of hydrops fetalis. Haematologica 2000;85:991–3
   PubMed Web of Science ®Google Scholar
• Ma ES, Chan AY, Au WY, et al. Diagnosis of concurrent hemoglobin H disease and heterozygous beta-thalassemia. Haematologica 2001;86:432–3
   PubMed Web of Science ®Google Scholar
• Tatu T, Kiewkarnkha T, Khuntarak S, et al. Screening for co-existence of alpha-thalassemia in beta-thalassemia and in HbE heterozygotes via an enzyme-linked immunosorbent assay for Hb Bart's and embryonic zeta-globin chain. Int J Hematol 2012;95:386–93
   PubMed Web of Science ®Google Scholar
• So CC, Chan AY, Luo HY, et al. Hb A2 Hong Kong – a novel delta-globin variant in a Chinese family masks the diagnosis of beta-thalassemia trait. Hemoglobin 2011;35:162–5
   PubMed Web of Science ®Google Scholar
• Madan N, Sikka M, Sharma S, Rusia U. Phenotypic expression of hemoglobin A2 in beta-thalassemia trait with iron deficiency. Ann Hematol 1998;77:93–6
   PubMed Web of Science ®Google Scholar
• Verhovsek M, So CC, O'Shea T, et al. Is HbA2 level a reliable diagnostic measurement for beta-thalassemia trait in people with iron deficiency? Am J Hematol 2012;87:114–6
   PubMed Web of Science ®Google Scholar
• McFarlane A, Warkentin TE, Cartin W. A novel sickling hemoglobinopathy. N Engl J Med 2011;365:1548–9
   Google Scholar
• So CC, Chan AY, Tsang ST, et al. A novel beta-delta globin gene fusion, anti-Lepore Hong Kong, leads to overexpression of delta globin chain and a mild thalassaemia intermedia phenotype when co-inherited with beta(0)-thalassaemia. Br J Haematol 2007;136:158–62
   PubMed Web of Science ®Google Scholar
• Pornprasert S, Sukunthamala K, Leechanachai P, Sanguansermsri T. Increased Hb A2 values in an HIV-1-infected patient receiving antiretroviral drugs: a pitfall for thalassemia antenatal diagnosis. Hemoglobin 2009;33:158–61
   PubMed Web of Science ®Google Scholar
• Au WY, Lee V, Lau CW, et al. A synopsis of current care of thalassaemia major patients in Hong Kong. Hong Kong Med J 2011;17:261–6
   Google Scholar
• Telfer P. Update on survival in thalassemia major. Hemoglobin 2009;33:S76–80
   PubMedGoogle Scholar
• Zhou X, Ha SY, Chan GC, et al. Successful mismatched sibling cord blood transplant in Hb Bart's disease. Bone Marrow Transplant 2001;28:105–7
   PubMed Web of Science ®Google Scholar
• Yi JS, Moertel CL, Baker KS. Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation. J Pediatr 2009;154:766–8
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M, Payen E, Negre O, et al. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia. Nature 2010;467:318–22
   PubMed Web of Science ®Google Scholar
• Nuinoon M, Makarasara W, Mushiroda T, et al. A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E. Hum Genet 2010;127:303–14
   PubMed Web of Science ®Google Scholar
• Galanello R, Sanna S, Perseu L, et al. Amelioration of Sardinian beta0 thalassemia by genetic modifiers. Blood 2009;114:3935–7
   PubMed Web of Science ®Google Scholar
• Badens C, Joly P, Agouti I, et al. Variants in genetic modifiers of beta-thalassemia can help to predict the major or intermedia type of the disease. Haematologica 2011;96:1712–4
   PubMed Web of Science ®Google Scholar
• Fucharoen S, Viprakasit V. Hb H disease: clinical course and disease modifiers. Hematology Am Soc Hematol Educ Program 2009;26–34
   PubMedGoogle Scholar
• Chen FE, Ooi C, Ha SY, et al. Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med 2000;343:544–50
   PubMed Web of Science ®Google Scholar
• Lal A, Goldrich ML, Haines DA, et al. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med 2011;364:710–18
   PubMed Web of Science ®Google Scholar
• Wajcman H, Traeger-Synodinos J, Papassotiriou I, et al. Unstable and thalassemic alpha chain hemoglobin variants: a cause of Hb H disease and thalassemia intermedia. Hemoglobin 2008;32:327–49
   PubMed Web of Science ®Google Scholar
• Chan V, Chan VW, Tang M, et al. Molecular defects in Hb H hydrops fetalis. Br J Haematol 1997;96:224–8
   PubMed Web of Science ®Google Scholar
• Henderson S, Pitman M, McCarthy J, et al. Molecular prenatal diagnosis of Hb H hydrops fetalis caused by haemoglobin Adana and the implications to antenatal screening for alpha-thalassaemia. Prenat Diagn 2008;28:859–61
   PubMed Web of Science ®Google Scholar
• Brillet T, Baudin-Creuza V, Vasseur C, et al. Alpha-hemoglobin stabilizing protein (AHSP), a kinetic scheme of the action of a human mutant, AHSPV56G. J Biol Chem 2010;285:17986–92
   PubMed Web of Science ®Google Scholar
• Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med 2013;3:a011775
   PubMed Web of Science ®Google Scholar
• Leung KY, Lee CP, Tang MH, et al. Cost-effectiveness of prenatal screening for thalassaemia in Hong Kong. Prenat Diagn 2004;24:899–907
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Flint AF, Pizzimenti MF, et al. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc Natl Acad Sci USA 1990;87:3279–83
   PubMed Web of Science ®Google Scholar
• Cheung MC, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 1996;14:264–8
   PubMed Web of Science ®Google Scholar
• Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–7
   PubMed Web of Science ®Google Scholar
• Hahn T, Drese KS, O'Sullivan CK. Microsystem for isolation of fetal DNA from maternal plasma by preparative size separation. Clin Chem 2009;55:2144–52
   PubMed Web of Science ®Google Scholar
• Ding C, Chiu RW, Lau TK, et al. MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 2004;101:10762–7
   PubMed Web of Science ®Google Scholar
• Tsang JC, Charoenkwan P, Chow KC, et al. Mass spectrometry-based detection of hemoglobin E mutation by allele-specific base extension reaction. Clin Chem 2007;53:2205–9
   PubMed Web of Science ®Google Scholar
• Chow KC, Chiu RW, Tsui NB, et al. Mass spectrometric detection of an SNP panel as an internal positive control for fetal DNA analysis in maternal plasma. Clin Chem 2007;53:141–2
   Google Scholar
• Chan KC, Ding C, Gerovassili A, et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006;52:2211–18
   PubMed Web of Science ®Google Scholar
• Chan K, Yam I, Leung KY, et al. Detection of paternal alleles in maternal plasma for non-invasive prenatal diagnosis of beta-thalassemia: a feasibility study in southern Chinese. Eur J Obstet Gynecol Reprod Biol 2010;150:28–33
   PubMed Web of Science ®Google Scholar
• Ho SS, Chong SS, Koay ES, et al. Noninvasive prenatal exclusion of haemoglobin Bart's using foetal DNA from maternal plasma. Prenat Diagn 2010;30:65–73
   Google Scholar
• Lun FM, Tsui NB, Chan KC, et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci USA 2008;105:19920–5
   PubMed Web of Science ®Google Scholar
• Lam KW, Jiang P, Liao GJ, et al. Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to beta-thalassemia. Clin Chem 2012;58:1467–75
   PubMed Web of Science ®Google Scholar
• Chan V, Ng EH, Yam I, et al. Experience in preimplantation genetic diagnosis for exclusion of homozygous alpha degrees thalassemia. Prenat Diagn 2006;26:1029–36
   PubMed Web of Science ®Google Scholar
• Yap C, Tan AS, Wang W, et al. First successful preimplantation genetic diagnosis in Singapore–avoidance of beta-thalassaemia major. Ann Acad Med Singapore 2009;38:720–3
   Google Scholar
• Handyside AH, Robinson MD, Simpson RJ, et al. Isothermal whole genome amplification from single and small numbers of cells: a new era for preimplantation genetic diagnosis of inherited disease. Mol Hum Reprod 2004;10:767–72
   PubMed Web of Science ®Google Scholar
• Huisman TH, Kutlar F, Gu LH. Gamma chain abnormalities and gamma-globin gene rearrangements in newborn babies of various populations. Hemoglobin 1991;15:349–79
   PubMed Web of Science ®Google Scholar
• Bento C, Magalhaes Maia T, Carvalhais I, et al. Transient neonatal cyanosis associated with a new Hb F variant: Hb F viseu. J Pediatr Hematol Oncol 2013;35:e77–80
   Google Scholar
• Zimmermann-Baer U, Capalo R, Dutly F, et al. Neonatal cyanosis due to a new (G)gamma-globin variant causing low oxygen affinity: Hb F-Sarajevo [(G)gamma102(G4)Asn→Thr, AAC > ACC]. Hemoglobin 2012;36:109–13
   PubMed Web of Science ®Google Scholar
• Garner C, Tatu T, Reittie JE, et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 2000;95:342–6
   PubMed Web of Science ®Google Scholar
• Anagnou NP, Perez-Stable C, Gelinas R, et al. Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice. J Biol Chem 1995;270:10256–63
   PubMedGoogle Scholar
• Feingold EA, Forget BG. The breakpoint of a large deletion causing hereditary persistence of fetal hemoglobin occurs within an erythroid DNA domain remote from the beta-globin gene cluster. Blood 1989;74:2178–86
   PubMed Web of Science ®Google Scholar
• Kosteas T, Palena A, Anagnou NP. Molecular cloning of the breakpoints of the hereditary persistence of fetal hemoglobin type-6 (HPFH-6) deletion and sequence analysis of the novel juxtaposed region from the 3' end of the beta-globin gene cluster. Hum Genet 1997;100:441–5
   PubMed Web of Science ®Google Scholar
• Sankaran VG, Xu J, Byron R, et al. A functional element necessary for fetal hemoglobin silencing. N Engl J Med 2011;365:807–14
   PubMed Web of Science ®Google Scholar
• Motum PI, Lindeman R, Harvey MP, Trent RJ. Comparative studies of nondeletional HPFH gamma-globin gene promoters. Exp Hematol 1993;21:852–8
   Google Scholar
• Chen Z, Luo HY, Basran RK, et al. A T-to-G transversion at nucleotide -567 upstream of HBG2 in a GATA-1 binding motif is associated with elevated hemoglobin F. Mol Cell Biol 2008;28:4386–93
   PubMed Web of Science ®Google Scholar
• Shimizu K, Park KS, Enoki Y. The XmnI site 5' to the G gamma-globin gene polymorphism and its relationship to %Hb F and %G gamma in normal Japanese and Korean adults. Hum Hered 1992;42:253–8
   Google Scholar
• So CC, Song YQ, Tsang ST, et al. The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia. J Med Genet 2008;45:745–51
   PubMed Web of Science ®Google Scholar
• Labie D, Pagnier J, Lapoumeroulie C, et al. Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci USA 1985;82:2111–14
   PubMed Web of Science ®Google Scholar
• Thein SL, Wainscoat JS, Sampietro M, et al. Association of thalassaemia intermedia with a beta-globin gene haplotype. Br J Haematol 1987;65:367–73
   PubMed Web of Science ®Google Scholar
• Haghi M, Feizi AA, Harteveld CL, et al. Homozygosity for a rare beta 0-thalassemia mutation [frameshift codons 25/26 (+T)] causes beta-thalassemia intermedia in an Iranian family. Hemoglobin 2009;33:75–80
   PubMed Web of Science ®Google Scholar
• Huang CH, Chang YY, Chen CH, Ko TM. Molecular characterization of a beta-globin gene deletion of 1357 bp in a Taiwanese beta-thalassemia carrier. Hemoglobin 2008;32:498–504
   PubMed Web of Science ®Google Scholar
• Dimovski AJ, Efremov DG, Jankovic L, et al. A beta zero-thalassaemia due to a 1605 bp deletion of the 5' beta-globin gene region. Br J Haematol 1993;85:143–7
   PubMed Web of Science ®Google Scholar
• Beris P, Kitundu MN, Baysal E, et al. Black beta-thalassemia homozygotes with specific sequence variations in the 5' hypersensitive site-2 of the locus control region have high levels of fetal hemoglobin. Am J Hematol 1992;41:97–101
   Google Scholar
• Papachatzopoulou A, Kaimakis P, Pourfarzad F, et al. Increased gamma-globin gene expression in beta-thalassemia intermedia patients correlates with a mutation in 3'HS1. Am J Hematol 2007;82:1005–9
   PubMed Web of Science ®Google Scholar
• Hamid M, Mahjoubi F, Akbari MT, et al. Molecular analysis of gamma-globin promoters, HS-111 and 3'HS1, in beta-thalassemia intermedia patients associated with high levels of Hb F. Hemoglobin 2009;33:428–38
   PubMed Web of Science ®Google Scholar
• Changsri K, Akkarapathumwong V, Jamsai D, et al. Molecular mechanism of high hemoglobin F production in Southeast Asian-type hereditary persistence of fetal hemoglobin. Int J Hematol 2006;83:229–37
   PubMed Web of Science ®Google Scholar
• Dimovski AJ, Divoky V, Adekile AD, et al. A novel deletion of approximately 27 kb including the beta-globin gene and the locus control region 3'HS-1 regulatory sequence: beta zero-thalassemia or hereditary persistence of fetal hemoglobin? Blood 1994;83:822–7
   PubMed Web of Science ®Google Scholar
• Menzel S, Garner C, Gut I, et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet 2007;39:1197–9
   PubMed Web of Science ®Google Scholar
• Sedgewick AE, Timofeev N, Sebastiani P, et al. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol Dis 2008;41:255–8
   PubMed Web of Science ®Google Scholar
• Uda M, Galanello R, Sanna S, et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci USA 2008;105:1620–5
   PubMed Web of Science ®Google Scholar
• Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 2008;322:1839–42
   PubMed Web of Science ®Google Scholar
• Sankaran VG, Xu J, Ragoczy T, et al. Developmental and species-divergent globin switching are driven by BCL11A. Nature 2009;460:1093–7
   PubMed Web of Science ®Google Scholar
• Wahlberg K, Jiang J, Rooks H, et al. The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells. Blood 2009;114:1254–62
   PubMed Web of Science ®Google Scholar
• Stadhouders R, Thongjuea S, Andrieu-Soler C, et al. Dynamic long-range chromatin interactions control Myb proto-oncogene transcription during erythroid development. EMBO J 2012;31:986–99
   PubMed Web of Science ®Google Scholar
• Jiang J, Best S, Menzel S, et al. cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 2006;108:1077–83
   PubMed Web of Science ®Google Scholar
• Farrell JJ, Sherva RM, Chen ZY, et al. A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood 2011;117:4935–45
   PubMed Web of Science ®Google Scholar
• Suzuki M, Yamazaki H, Mukai HY, et al. Disruption of the Hbs1l-Myb locus causes hereditary persistence of fetal hemoglobin in a mouse model. Mol Cell Biol 2013;33:1687–95
   PubMed Web of Science ®Google Scholar
• Drissen R, Palstra RJ, Gillemans N, et al. The active spatial organization of the beta-globin locus requires the transcription factor EKLF. Genes Dev 2004;18:2485–90
   PubMed Web of Science ®Google Scholar
• Zhou D, Liu K, Sun CW, et al. KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching. Nat Genet 2010;42:742–4
   PubMed Web of Science ®Google Scholar
• Tallack MR, Perkins AC. Three fingers on the switch: Kruppel-like factor 1 regulation of gamma-globin to beta-globin gene switching. Curr Opin Hematol 2013;20:193–200
   PubMed Web of Science ®Google Scholar
• Borg J, Papadopoulos P, Georgitsi M, et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet 2010;42:801–5
   PubMed Web of Science ®Google Scholar
• Lettre G, Sankaran VG, Bezerra MA, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA 2008;105:11869–74
   PubMed Web of Science ®Google Scholar